TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
DXCM

DexCom Inc

Healthcare · Medical Devices

87.50$ -0.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

DexCom Inc (DXCM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 6,455 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DXCM
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
362 403 467 796 843 904 897 1,008 1,114 1,916 1,974 2,066 2,186 2,395 2,448 3,522 3,833 4,291 4,390 4,504 4,776 4,933 5,057 5,217 4,899 5,392 5,516 6,821 6,596 6,265 6,482 6,799 6,354 6,485 6,752 7,327 7,500 6,340 6,633 6,455
259 280 331 657 693 745 729 836 914 1,700 1,691 1,744 1,816 1,969 1,996 3,033 3,237 3,425 3,445 3,474 3,656 3,684 3,747 3,809 3,399 3,669 3,767 5,003 4,698 4,426 4,621 4,848 4,263 4,301 4,554 5,030 5,220 4,033 4,332 4,087
98 95 154 396 402 442 420 300 367 1,137 1,285 709 396 446 585 530 674 818 734 1,159 1,444 1,053 716 735 698 642 623 1,195 644 566 851 939 621 606 905 1,159 1,836 918 1,118 1,105
127 124 181 497 526 549 534 606 669 1,386 1,358 1,378 1,430 1,533 1,511 2,509 2,604 2,708 2,633 2,585 2,698 2,731 2,688 2,755 2,372 2,456 2,567 3,636 3,240 2,724 2,897 3,121 2,492 2,579 2,701 2,929 3,322 1,999 2,415 1,947
77 102 86 102 111 134 124 162 170 227 205 217 235 286 301 297 370 429 443 484 529 517 545 612 597 752 653 756 789 988 985 999 1,034 1,034 1,170 1,377 1,169 1,290 1,105 1,283
45 45 47 43 43 45 52 46 55 71 101 118 120 120 142 165 201 235 290 319 351 357 342 340 311 307 366 421 499 560 589 570 586 543 538 571 604 629 694 726
88 109 123 125 136 146 152 157 170 183 221 253 301 321 346 384 462 515 689 771 834 890 857 943 1,003 1,136 1,076 – 1,152 – – – – – – – – – – –
12 11 11 12 12 12 12 12 18 19 19 19 18 19 19 19 19 19 19 19 24 27 27 26 25 26 26 26 25 25 23 23 24 23 23 24 24 24 24 24
1.6 0.2 11 12 12 12 12 12 18 – – – – – – – – 21 19 – 46 32 31 28 24 173 164 154 145 135 123 115 106 103 95 87 79 71 63 102
100 119 189 442 459 485 475 525 552 1,253 1,305 1,378 1,421 1,512 1,513 2,168 2,334 2,464 2,487 2,506 2,640 2,891 2,868 2,962 3,075 3,260 3,283 4,720 4,328 4,196 4,235 4,365 4,375 4,382 4,485 4,754 4,774 3,594 3,676 3,834
86 102 172 105 118 139 125 171 194 222 235 288 322 360 343 400 506 614 604 601 735 721 711 807 901 1,839 1,865 2,070 1,679 1,556 1,594 1,722 1,735 2,932 3,037 3,309 3,336 2,143 2,224 2,358
3.7 39 75 14 11 33 40 15 18 60 12 14 15 14 15 15 16 17 18 19 19 21 21 21 21 793 795 796 145 21 21 22 22 1,227 1,228 1,230 1,231 22 21 21
26 68 18 17 23 87 88 60 58 147 90 97 101 102 110 108 148 163 152 166 210 189 150 220 198 238 266 269 242 276 270 307 327 345 432 472 452 344 394 424
6.0 0.0 6.7 321 324 328 331 335 339 1,010 1,022 1,035 1,047 1,060 1,072 1,659 1,646 1,667 1,689 1,711 1,704 1,703 1,966 1,967 1,969 1,198 1,199 2,431 2,432 2,434 2,436 2,438 2,440 1,237 1,238 1,239 1,240 1,241 1,242 1,243
262 284 278 354 384 419 422 482 562 663 669 688 764 883 935 1,354 1,499 1,827 1,903 1,998 2,136 2,042 2,189 2,256 1,825 2,132 2,233 2,100 2,268 2,069 2,247 2,434 1,979 2,103 2,267 2,573 2,726 2,746 2,957 2,621
-614 -621 -663 -660 -662 -672 -696 -666 -619 -799 -824 -834 -788 -696 -676 -630 -557 -202 -162 -99 -28 139 236 287 388 480 529 644 765 1,021 1,168 1,311 1,446 1,598 1,703 1,883 2,167 2,434 2,633 2,883
336 338 341 350 347 348 349 358 361 355 361 364 370 371 376 388 398 390 418 427 430 388 429 421 426 426 419 432 427 416 417 417 410 407 408 408 407 399 394 392

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?